• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,039.12 535.52
( 0.70%)
Global Indices
Nasdaq
52,357.11 -589.04
(-1.11%)
Dow Jones
7,503.65 -21.20
(-0.28%)
Hang Seng
67,213.51 -1,043.45
(-1.53%)
Nikkei 225
10,469.05 -196.83
(-1.85%)
Forex
USD-INR
95.15 -0.21
(-0.22%)
EUR-INR
108.73 -0.26
(-0.24%)
GBP-INR
127.27 -0.11
(-0.09%)
JPY-INR
0.59 0.00
(-0.14%)

EQUITY - MARKET SCREENER

Hikal Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
524735
INE475B01022
97.2386745
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
HIKAL
77.58
2821.74
EPS(TTM)
Face Value()
Div & Yield %
2.95
2
0.18
 

Triveni Engineering and Industries consolidated net profit declines 8.50% in the March 2026 quarter
May 30,2026
Net profit of Triveni Engineering and Industries declined 8.50% to Rs 167.45 crore in the quarter ended March 2026 as against Rs 183.00 crore during the previous quarter ended March 2025. Sales declined 7.45% to Rs 1507.98 crore in the quarter ended March 2026 as against Rs 1629.29 crore during the previous quarter ended March 2025.

For the full year,net profit rose 10.49% to Rs 268.71 crore in the year ended March 2026 as against Rs 243.19 crore during the previous year ended March 2025. Sales rose 10.57% to Rs 6290.49 crore in the year ended March 2026 as against Rs 5689.24 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1507.981629.29 -7 6290.495689.24 11
OPM %18.3618.91 -8.698.37 -
PBDT257.41287.28 -10 522.36450.39 16
PBT221.00255.17 -13 378.20324.23 17
NP167.45183.00 -8 268.71243.19 10